For example, although some studies have shown that PD-1 and chemotherapeutic agents such as cisplatin can improve the survival time of some patients with nasopharyngeal carcinoma, the expression of PDL1 in most patients with nasopharyngeal carcinoma is low. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.